drugset / Trial / NCT03043521
Pharmacodynamic Properties of CJ-12420 on Evening Dosing
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare and evaluate impact on pharmacodynamic characteristics of CJ-12420 and dexlansoprazole with evening dosing in healthy male volunteers
Timeline
- Start
- 2015-05-13
- Primary completion
- 2015-08-12
- Completion
- 2015-08-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexlansoprazole | Other / unclassified | 60 mg | — |
| Subject | Tegoprazan | Other / unclassified | 50 mg | — |
| Subject | Tegoprazan | Other / unclassified | 100 mg | — |
| Subject | Tegoprazan | Other / unclassified | 200 mg | — |
Indications
No indication recorded.